| Symbol |
Name |
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AR
|
androgen receptor
|
|
ARR3
|
arrestin 3, retinal (X-arrestin)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CD38
|
CD38 molecule
|
|
COX8A
|
cytochrome c oxidase subunit VIIIA (ubiquitous)
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
EDA
|
ectodysplasin A
|
|
EDARADD
|
EDAR-associated death domain
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL4
|
interleukin 4
|
|
MPO
|
myeloperoxidase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NSDHL
|
NAD(P) dependent steroid dehydrogenase-like
|
|
PREP
|
prolyl endopeptidase
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PROKR2
|
prokineticin receptor 2
|
|
SHARPIN
|
SHANK-associated RH domain interactor
|
|
SIRT1
|
sirtuin 1
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPIN2A
|
spindlin family, member 2A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIM13
|
tripartite motif containing 13
|
